Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT02946658
Eligibility Criteria:
Inclusion Criteria:
* Prior Diagnosis of moderate to severe COPD
* GOLD II a, III, IV
Exclusion Criteria:
* Pregnant or Lactating Females
* Life expectancy of \< 3 months due to concomitant illnesses
* Exposure to any investigational drug or procedure with 1 month prior to study entry or enrollment in concurrent study which may interfere with interpretation of study results
* Illness which, in investigators judgement, may interfere with the patient' ability to comply with protocol, compromise patient safety, ability to provide informed consent to study, or interfere with interpretation of study outcomes
* Subjects on chronic immunosuppressive or chemotherapeutic medications
* Known drug or alcohol dependence or other factors which may interfere with study conduct or interpretation of result or in the opinion of investigator are not suitable to participate.
* Subjects with documented Alpha-1 Antitrypsin Deficiency (Inherited lung and liver disorder)
* Unwilling or not competent to understand and execute an informed consent agreement
* Patients positive for Hepatitis (Hepatitis A history excepted)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02946658
Study Brief:
Protocol Section:
NCT02946658